Movement Alert｜GenScript Biotech Rises 5.12% in Regular Trading, Legend Biotech ASCO Data Releases Boost Sentiment

Market Focus05-27

On May 27, GenScript Biotech rose 5.12% in regular trading, trading at HKD 14.04/share, with trading volume of HKD 45.87 million.

On the news front, GenScript previously announced that its associate company Legend Biotech will present multiple research results at the ASCO Annual Meeting. A rapid oral presentation will highlight Phase 1 preliminary data for LB2102, an investigational DLL3-targeting CAR-T therapy for relapsed or refractory small cell lung cancer and large cell neuroendocrine carcinoma. New CARVYKTI data will also be disclosed at the conference.

The expansion of CAR-T therapy into solid tumor indications opens significant growth potential for the company. Meanwhile, market discussions around GenScript's valuation inversion — where its total market capitalization (approximately USD 4.78 billion) remains below the value of its approximately 47% stake in Legend Biotech (approximately USD 2.64 billion), implying negative value for its remaining life sciences, CDMO, and synthetic biology businesses — have further supported short-term sentiment recovery and driven the share price rebound.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1122556497?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-27 09:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122556497","market":"us","top_or_hot":-1,"title":"Movement Alert｜GenScript Biotech Rises 5.12% in Regular Trading, Legend Biotech ASCO Data Releases Boost Sentiment","media":"Market Focus","content":"<p><p>On May 27, GenScript Biotech rose 5.12% in regular trading, trading at HKD 14.04/share, with trading volume of HKD 45.87 million.</p><p>On the news front, GenScript previously announced that its associate company Legend Biotech will present multiple research results at the ASCO Annual Meeting. A rapid oral presentation will highlight Phase 1 preliminary data for LB2102, an investigational DLL3-targeting CAR-T therapy for relapsed or refractory small cell lung cancer and large cell neuroendocrine carcinoma. New CARVYKTI data will also be disclosed at the conference.</p><p>The expansion of CAR-T therapy into solid tumor indications opens significant growth potential for the company. Meanwhile, market discussions around GenScript's valuation inversion — where its total market capitalization (approximately USD 4.78 billion) remains below the value of its approximately 47% stake in Legend Biotech (approximately USD 2.64 billion), implying negative value for its remaining life sciences, CDMO, and synthetic biology businesses — have further supported short-term sentiment recovery and driven the share price rebound.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜GenScript Biotech Rises 5.12% in Regular Trading, Legend Biotech ASCO Data Releases Boost Sentiment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜GenScript Biotech Rises 5.12% in Regular Trading, Legend Biotech ASCO Data Releases Boost Sentiment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-05-27 09:49</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On May 27, GenScript Biotech rose 5.12% in regular trading, trading at HKD 14.04/share, with trading volume of HKD 45.87 million.</p><p>On the news front, GenScript previously announced that its associate company Legend Biotech will present multiple research results at the ASCO Annual Meeting. A rapid oral presentation will highlight Phase 1 preliminary data for LB2102, an investigational DLL3-targeting CAR-T therapy for relapsed or refractory small cell lung cancer and large cell neuroendocrine carcinoma. New CARVYKTI data will also be disclosed at the conference.</p><p>The expansion of CAR-T therapy into solid tumor indications opens significant growth potential for the company. Meanwhile, market discussions around GenScript's valuation inversion — where its total market capitalization (approximately USD 4.78 billion) remains below the value of its approximately 47% stake in Legend Biotech (approximately USD 2.64 billion), implying negative value for its remaining life sciences, CDMO, and synthetic biology businesses — have further supported short-term sentiment recovery and driven the share price rebound.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01548","symbol_name":"金斯瑞生物科技","start_time":0,"source_url":"","article_id":"1122556497","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122556497","pubTimestamp":1779846542,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On May 27, GenScript Biotech rose 5.12% in regular trading, trading at HKD 14.04/share, with trading volume of HKD 45.87 million.On the news front, GenScript previously announced that its associate...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01548":"金斯瑞生物科技"},"translate_title":"动向提示|金斯瑞生物常规交易涨5.12%传奇生物ASCO数据公布提振人气","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01548":1},"content_text":"On May 27, GenScript Biotech rose 5.12% in regular trading, trading at HKD 14.04/share, with trading volume of HKD 45.87 million.On the news front, GenScript previously announced that its associate company Legend Biotech will present multiple research results at the ASCO Annual Meeting. A rapid oral presentation will highlight Phase 1 preliminary data for LB2102, an investigational DLL3-targeting CAR-T therapy for relapsed or refractory small cell lung cancer and large cell neuroendocrine carcinoma. New CARVYKTI data will also be disclosed at the conference.The expansion of CAR-T therapy into solid tumor indications opens significant growth potential for the company. Meanwhile, market discussions around GenScript's valuation inversion — where its total market capitalization (approximately USD 4.78 billion) remains below the value of its approximately 47% stake in Legend Biotech (approximately USD 2.64 billion), implying negative value for its remaining life sciences, CDMO, and synthetic biology businesses — have further supported short-term sentiment recovery and driven the share price rebound.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.3","shortVersion":"4.42.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1122556497","isCrawlerRequest":true}